Medtronic (MDT) Stock Forecast & Price Target

$89.42 +1.48 (+1.68%)

As of 11:51 AM Eastern

Medtronic - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 16 Analyst Ratings

Sell
1

Hold
9

Buy
6

Based on 16 Wall Street analysts who have issued ratings for Medtronic in the last 12 months, the stock has a consensus rating of "Hold." Out of the 16 analysts, 1 has given a sell rating, 9 have given a hold rating, 5 have given a buy rating, and 1 has given a strong buy rating for MDT.

Consensus Price Target

$95.00
6.24% Upside

According to the 16 analysts' twelve-month price targets for Medtronic, the average price target is $95.00. The highest price target for MDT is $109.00, while the lowest price target for MDT is $83.00. The average price target represents a forecasted upside of 6.24% from the current price of $89.42.

Get the Latest News and Ratings for MDT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Medtronic and its competitors.

MDT Analyst Ratings Over Time

Type	Current Forecast 2/22/24 to 2/21/25	1 Month Ago 1/23/24 to 1/22/25	3 Months Ago 11/24/23 to 11/23/24	1 Year Ago 2/22/23 to 2/22/24
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	6 Buy rating(s)	6 Buy rating(s)	6 Buy rating(s)
Hold	9 Hold rating(s)	9 Hold rating(s)	9 Hold rating(s)	4 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$95.00	$95.00	$95.00	$94.25
Forecasted Upside	6.24% Upside	8.15% Upside	10.20% Upside	10.80% Upside
Consensus Rating	Hold	Hold	Hold	Hold

MDT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MDT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Medtronic Stock vs. The Competition

Type	Medtronic	Medical Companies	S&P 500
Consensus Rating Score	2.38	2.82	2.53
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	7.78% Upside	29,063.69% Upside	12.82% Upside
News Sentiment Rating	Positive News See Recent MDT News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
2/19/2025	Royal Bank of Canada 4 of 5 stars	S. Singh Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$105.00 ➝ $105.00	+21.79%
2/19/2025	UBS Group 4 of 5 stars	Danielle Antalffy Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$85.00 ➝ $95.00	+10.40%
2/19/2025	Needham & Company LLC 2 of 5 stars	Mike Matson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
2/19/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Rescott Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$90.00 ➝ $91.00	+5.75%
12/18/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$93.00 ➝ $89.00	+9.44%
11/26/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$105.00 ➝ $109.00	+27.11%
11/20/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$96.00 ➝ $97.00	+15.68%
11/20/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$106.00 ➝ $98.00	+13.95%
11/15/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$99.00 ➝ $96.00	+9.84%
10/1/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$85.00 ➝ $92.00	+2.76%
Get the Latest News and Ratings for MDT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.
10/1/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$100.00 ➝ $104.00	+16.16%
8/23/2024	Daiwa America Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Department Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/21/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$85.00 ➝ $90.00	+4.41%
8/21/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$85.00 ➝ $87.00	+1.90%
8/21/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$92.00 ➝ $94.00	+10.10%
5/30/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Sell	$83.00	+1.84%
2/21/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$95.00 ➝ $98.00	+14.71%
11/22/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$104.00 ➝ $98.00	+24.68%
6/30/2023	22nd Century Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Initiates
6/30/2023	CL King Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$106.00	+22.16%
2/22/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$80.00 ➝ $87.00	+1.12%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 11:37 AM ET.

Should I Buy Medtronic Stock? MDT Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, February 16, 2025. Please send any questions or comments about these Medtronic pros and cons to contact@marketbeat.com.

Medtronic
Bull Case

Here are some ways that investors could benefit from investing in Medtronic plc:

Medtronic plc reported a strong earnings per share (EPS) of $1.26 for the latest quarter, exceeding analysts' expectations of $1.25. This indicates robust financial performance and potential for continued growth.
The company achieved a revenue of $8.40 billion, surpassing the consensus estimate of $8.27 billion, reflecting a year-over-year revenue increase of 5.2%. This growth suggests a solid demand for its medical technologies.
Medtronic plc has announced a quarterly dividend of $0.70 per share, translating to an annualized dividend of $2.80 and a dividend yield of 3.01%. This consistent dividend payment can provide a steady income stream for investors.
Analysts forecast an EPS of 5.45 for the current fiscal year, indicating expectations of continued profitability and growth potential for the company.
The current stock price is around $90.00, which may present a buying opportunity for investors looking to enter at a favorable valuation compared to its historical performance.

Medtronic
Bear Case

Investors should be bearish about investing in Medtronic plc for these reasons:

The company's payout ratio is currently at 85.63%, which indicates that a significant portion of earnings is being distributed as dividends. This could limit the funds available for reinvestment in growth initiatives.
Recent insider selling, including a transaction where an executive vice president sold 12,437 shares, may raise concerns about the company's future performance and insider confidence.
Several analysts have downgraded their price targets for Medtronic plc, with some reducing their expectations from $96.00 to $89.00, which could signal a bearish outlook among market experts.
Despite the positive revenue growth, the net margin of 13.00% may suggest that the company faces challenges in maintaining profitability amidst rising costs in the medical technology sector.
With a consensus rating of "Hold" from analysts, there may be limited upside potential in the stock, indicating that investors should be cautious about expecting significant price appreciation in the near term.

MDT Forecast - Frequently Asked Questions

: According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Medtronic is $95.00, with a high forecast of $109.00 and a low forecast of $83.00.
: 16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There is currently 1 sell rating, 9 hold ratings, 5 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" MDT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDT, but not buy additional shares or sell existing shares.
: According to analysts, Medtronic's stock has a predicted upside of 6.24% based on their 12-month stock forecasts.
: Medtronic has been rated by research analysts at Barclays, Needham & Company LLC, Robert W. Baird, Royal Bank of Canada, Truist Financial, and UBS Group in the past 90 days.
: Analysts like Medtronic less than other "medical" companies. The consensus rating for Medtronic is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MDT compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:MDT) was last updated on 2/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Medtronic (MDT) Stock Forecast & Price Target